Voloridge Investment Management’s 4D Molecular Therapeutics FDMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-84,175
| Closed | -$272K | – | 1235 |
|
|
2025
Q1 | $272K | Sell |
84,175
-99,724
| -54% | -$322K | ﹤0.01% | 1128 |
|
|
2024
Q4 | $1.02M | Sell |
183,899
-106,132
| -37% | -$591K | ﹤0.01% | 1037 |
|
|
2024
Q3 | $3.14M | Sell |
290,031
-71,666
| -20% | -$775K | 0.01% | 867 |
|
|
2024
Q2 | $7.59M | Sell |
361,697
-19,382
| -5% | -$407K | 0.03% | 641 |
|
|
2024
Q1 | $12.1M | Buy |
381,079
+361,385
| +1,835% | +$11.5M | 0.04% | 439 |
|
|
2023
Q4 | $399K | Sell |
19,694
-53,073
| -73% | -$1.08M | ﹤0.01% | 1053 |
|
|
2023
Q3 | $926K | Sell |
72,767
-62,894
| -46% | -$801K | ﹤0.01% | 1112 |
|
|
2023
Q2 | $2.45M | Buy |
135,661
+23,563
| +21% | +$426K | 0.01% | 928 |
|
|
2023
Q1 | $1.93M | Buy |
+112,098
| New | +$1.93M | 0.01% | 986 |
|